NICHD: Maternal Antibody Treatment Fails to Reduce Infant Cytomegalovirus Infection, NIH-Funded Study Suggests
August 25, 2021
August 25, 2021
ROCKVILLE, Maryland, Aug. 25 -- The National Institutes of Health's Eunice Kennedy Shriver National Institute of Child's Health and Human Development issued the following news release:
An antibody treatment in early pregnancy for women infected with cytomegalovirus does not appear to reduce the risk of infection or death among their newborns, an NIH-funded study suggests. The findings contradict several smaller studies on the treatment, known as hyperimmune globulin, that . . .
An antibody treatment in early pregnancy for women infected with cytomegalovirus does not appear to reduce the risk of infection or death among their newborns, an NIH-funded study suggests. The findings contradict several smaller studies on the treatment, known as hyperimmune globulin, that . . .